Table 1.
Association between the expression of YY1, miR-141 and NPC clinical pathological features (n = 126)
The following abbreviations were used: DNC, differentiated nonkeratinized nasopharyngeal carcinoma; UDNC, undifferentiated non-eratinized nasopharyngeal carcinoma; H, high expression; L, low expression. Statistical analysis was performed using the Chi-squared test. *, p < 0.05; ***, p < 0.001.
| Characteristics (N) | YY1 |
miR-141 |
YY1/miR-141 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| H (%) | L (%) | p value | H (%) | L (%) | p value | H-L (%) | l-H (%) | p value | |
| Age (year) | |||||||||
| ≤40 (n = 52) | 29 | 71 | 0.7156 | 88 | 12 | 0.8325 | 6 | 67 | 0.6587 |
| >40 (n = 74) | 23 | 77 | 81 | 19 | 11 | 65 | |||
| Gender | |||||||||
| Female (n = 25) | 23 | 77 | 0.5013 | 84 | 16 | 0.9316 | 8 | 68 | 0.8474 |
| Male (n = 101) | 32 | 68 | 84 | 16 | 9 | 65 | |||
| Histological type | |||||||||
| DNC (n = 33) | 18 | 82 | 0.3481 | 82 | 18 | 0.664 | 9 | 61 | 0.5624 |
| UDNC (n = 93) | 28 | 72 | 85 | 15 | 9 | 68 | |||
| Clinical stages | |||||||||
| Stage I (n = 15) | 60 | 40 | 0.0247* | 67 | 33 | <0.001*** | 27 | 40 | 0.0158* |
| Stage II (n = 52) | 25 | 75 | 77 | 23 | 6 | 56 | |||
| Stage III (n = 34) | 24 | 76 | 97 | 3 | 6 | 74 | |||
| Stage IV (n = 25) | 8 | 92 | 92 | 8 | 0 | 92 | |||